Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ingenza announced its relocation to The Moubray Building at Edinburgh Technopole, part of the Pioneer Group. The new site is still within the Midlothian Science Zone – a world-leading center of research excellence in life sciences – and is now fully ...
read more
Edinburgh-based Ingenza has increased its footprint to over 12,000 sq ft within the Roslin Innovation Centre.
read more
Thursday, October 10, 2024
Ingenza, a contract research, development and manufacturing organization (CRDMO) and technology accelerator, announced its plans to relocate to the Moubray Building at Edinburgh Technopole, part of Pioneer Group.
read more
Thursday, October 03, 2024
Ingenza a contract research, development and manufacturing organization (CRDMO) and technology accelerator announced its plans to relocate to the Moubray Building at Edinburgh Technopole, part of Pioneer Group.
read more
Arecor has announced its partner, Inhibrx, has exercised an option to license a novel enhanced formulation of Inhibrx's proprietary therapeutic candidate, INBRX-101, developed by Arecor.
read more
Monday, December 23, 2019
Lacutamab will not be administered to new patients in the TELLOMAK trial until additional feedback is received from the respective regulatory agencies overseeing our clinical trial.
read more
Tuesday, October 05, 2021
Innodem Neurosciences announced that it has signed a multi-year partnership agreement with Novartis Pharmaceuticals Canada Inc. (Novartis) to conduct a breakthrough clinical trial to help people living with multiple sclerosis (MS).
read more
Friday, December 02, 2022
Innoforce announced that it has commenced GMP manufacturing at its new site in Hangzhou, China. The new facility is built to offer process development & manufacturing services for the global supply of RNA, plasmid DNA, viral vectors, and cell ...
read more
Monday, February 06, 2017
Innomar Strategies, a specialty drug service provider, and a part of AmerisourceBergen, is adding another distribution center and three specialty pharmacies to the company’s existing specialty solutions infrastructure. The new locations will further ...
read more
Wednesday, April 20, 2016
Innophos Holdings, Inc. has announced the appointment of Amy Hartzell as Vice President, Supply Chain and Purchasing, which was effective April 13, 2016.
read more
Innovaderm announced a major rebranding to Indero. The new brand identity reinforces the company’s dual focus on rheumatology and dermatology and recognizes the close synergy between these fields.
read more
Tuesday, November 28, 2023
Thermo Fisher Scientific Inc. and Flagship Pioneering have unveiled a strategic partnership aimed at the rapid development and commercial scaling of multiproduct platforms.
read more
Innovative Targeting Solutions announced a research agreement with Eli Lilly and Company.
read more
Tuesday, October 15, 2019
Innoveix Pharmaceuticals is voluntarily recalling all sterile compounded drug products, within expiry, to the consumer level
read more
Thursday, January 02, 2025
Innovent Biologics, Inc. announced a collaboration and exclusive license agreement with Roche to advance the development of IBI3009, a novel DLL3-targeted antibody drug conjugate (ADC) candidate. IBI3009 has already obtained IND approvals in ...
read more